BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

938 related articles for article (PubMed ID: 29410711)

  • 21. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.
    Lou N; Ruan AM; Qiu B; Bao L; Xu YC; Zhao Y; Sun RL; Zhang ST; Xu GH; Ruan HL; Yuan CF; Han WW; Shi HC; Yang HM; Zhang XP
    Urol Oncol; 2017 Jan; 35(1):36.e7-36.e14. PubMed ID: 27633984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered Expression of DDR1 in Clear Cell Renal Cell Carcinoma Correlates With miR-199a/b-5p and Patients' Outcome.
    Krazinski BE; Kiewisz J; Sliwinska-Jewsiewicka A; Kowalczyk AE; Grzegrzolka J; Godlewski J; Kwiatkowski P; Dziegiel P; Kmiec Z
    Cancer Genomics Proteomics; 2019; 16(3):179-193. PubMed ID: 31018949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.
    Wotschofsky Z; Gummlich L; Liep J; Stephan C; Kilic E; Jung K; Billaud JN; Meyer HA
    PLoS One; 2016; 11(2):e0148746. PubMed ID: 26859141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging role of secreted miR-210-3p as potential biomarker for clear cell Renal Cell Carcinoma metastasis.
    Petrozza V; Costantini M; Tito C; Giammusso LM; Sorrentino V; Cacciotti J; Porta N; Iaiza A; Pastore AL; Di Carlo A; Simone G; Carbone A; Gallucci M; Fazi F
    Cancer Biomark; 2020; 27(2):181-188. PubMed ID: 31771042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary miRNAs Predict Metastasis in Patients With Clinically Localized Clear Cell Renal Cell Carcinoma Treated With Nephrectomy.
    Borges Dos Reis R; Shu X; Ye Y; Borregales L; Karam JA; Adibi M; Wu X; Reis LO; Wood CG
    Clin Genitourin Cancer; 2024 Feb; 22(1):e156-e162.e4. PubMed ID: 37945405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma.
    Friedrich M; Heimer N; Stoehr C; Steven A; Wach S; Taubert H; Hartmann A; Seliger B
    Sci Rep; 2020 Apr; 10(1):6499. PubMed ID: 32300145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma.
    Liu S; Deng X; Zhang J
    Mol Med Rep; 2019 Dec; 20(6):5075-5083. PubMed ID: 31661117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

  • 29. Profiling microRNA from nephrectomy and biopsy specimens: predictors of progression and survival in clear cell renal cell carcinoma.
    Kowalik CG; Palmer DA; Sullivan TB; Teebagy PA; Dugan JM; Libertino JA; Burks EJ; Canes D; Rieger-Christ KM
    BJU Int; 2017 Sep; 120(3):428-440. PubMed ID: 28432832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.
    Chen X; Ruan A; Wang X; Han W; Wang R; Lou N; Ruan H; Qiu B; Yang H; Zhang X
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1295-304. PubMed ID: 24802708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of miR-183-5p predicts worse survival in patients with renal cell cancer after surgery.
    Li H; Pan X; Gui Y; Quan J; Li Z; Zhao L; Guan X; Xu J; Xu W; Lai Y
    Cancer Biomark; 2019; 24(2):153-158. PubMed ID: 30689558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease.
    Moynihan MJ; Sullivan TB; Burks E; Schober J; Calabrese M; Fredrick A; Kalantzakos T; Warrick J; Canes D; Raman JD; Rieger-Christ K
    Urol Oncol; 2020 Oct; 38(10):799.e11-799.e22. PubMed ID: 32534961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Liu Q; Lei C
    Ann Med; 2021 Dec; 53(1):2153-2164. PubMed ID: 34783622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circular RNA hsa_circ_001895 serves as a sponge of microRNA-296-5p to promote clear cell renal cell carcinoma progression by regulating SOX12.
    Chen Z; Xiao K; Chen S; Huang Z; Ye Y; Chen T
    Cancer Sci; 2020 Feb; 111(2):713-726. PubMed ID: 31782868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients.
    Slaby O; Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R
    Genes Chromosomes Cancer; 2012 Jul; 51(7):707-16. PubMed ID: 22492545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
    Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
    Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
    Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.
    Gowrishankar B; Ibragimova I; Zhou Y; Slifker MJ; Devarajan K; Al-Saleem T; Uzzo RG; Cairns P
    Cancer Biol Ther; 2014 Mar; 15(3):329-41. PubMed ID: 24351440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.